Q32 Bio
QTTB | NASDAQ
$8.29
-$0.42 (-4.82%)
At close: Nov 16, 2026, 4:00 PM ET
$8.29
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.82%
(1D)No price chart data available for 1D timeframe.
Rating
72.8
Fundamentals Excellent
Market Sentiment Neutral
Moat None
Sector Rank #39/1021 (Top 4%)
Key Statistics
Market Data
Market Cap $248.07M
1D Range
8.25 8.73
52W Range
1.93 21.38
Valuation (TTM)
PE 2.65
PB 0.86
EV/EBITDA -1.18
Valuation (NTM)
Forward PE N/A
Forward PEG -0.05
Price Target $35.00
Cash Flow
FCF Yield -8.1%
SBC Adj. FCF Yield -11.2%
SBC Impact -37.9%
Margins
Gross Margin 99.8%
Operating Margin 34.2%
FCF Margin -37.3%
Growth (CAGR)
Revenue 3Y | 5Y 65.8% |
9.5%
Dil EPS 3Y | 5Y 176.3% |
32.3%
FCF 3Y | 5Y 56.0% |
31.1%
Returns
ROA 10.8%
ROE 26.8%
ROIC 6.3%
Financial Health
Net Cash
$285.22M
Current Ratio 56.34
Interest Coverage 18.38
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States su...
Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Mar 28, 2018
Website www.q32bio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.26
Beat +20.41%
YoY:
+56.67% REV
$170K
Beat 0.00%
Next Earnings
Mar 9, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$35.00
Upside
+322.20%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove QTTB